Generalizability of the results of efficacy trials in first episode schizophrenia / Han Boter en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 1 (Enero)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 1 (Enero) . - pp. 58-65 Título : Generalizability of the results of efficacy trials in first episode schizophrenia : comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST) Tipo de documento: texto impreso Autores: Han Boter, Autor ; Eske M. Derks, Autor ; W. Wolfgang Fleischhacker, Autor Fecha de publicación: 2022 Artículo en la página: pp. 58-65 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Esquizofrenia, Trastornos relacionados con sustancias, Intento de suicidio. Resumen: Most randomized drug trials in schizophrenia exclude patients with comorbidities such as suicidality or substance use, which may limit the generalizability of the results. We aimed to evaluate the generalizability of the results of these trials in participants of a randomized clinical trial with broad inclusion criteria. Link: ./index.php?lvl=notice_display&id=28126 [artículo] Generalizability of the results of efficacy trials in first episode schizophrenia : comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST) [texto impreso] / Han Boter, Autor ; Eske M. Derks, Autor ; W. Wolfgang Fleischhacker, Autor . - 2022 . - pp. 58-65. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 1 (Enero) . - pp. 58-65 Palabras clave: Antipsicóticos, Esquizofrenia, Trastornos relacionados con sustancias, Intento de suicidio. Resumen: Most randomized drug trials in schizophrenia exclude patients with comorbidities such as suicidality or substance use, which may limit the generalizability of the results. We aimed to evaluate the generalizability of the results of these trials in participants of a randomized clinical trial with broad inclusion criteria. Link: ./index.php?lvl=notice_display&id=28126

---

1 (1 - 1 / 1)